Biocure Technology Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.04	0.02	0	0.04	0.16
Cash & Short-Term Investments	0.04	0.02	0	0.04	0.16
Cash Growth	130.79%	323.82%	-88.76%	-76.32%	240.83%
Other Receivables	0	0.01	0.01	0.02	0.01
Receivables	0	0.01	0.01	0.02	0.01
Inventory	-	-	-	-	0
Prepaid Expenses	0	-	-	-	0.07
Other Current Assets	-	-	-	0.06	1.89
Total Current Assets	0.05	0.03	0.01	0.12	2.13
Property, Plant & Equipment	-	-	-	-	0.01
Long-Term Investments	1.97	1.97	1.97	1.97	1.97
Other Intangible Assets	-	-	-	-	0
Other Long-Term Assets	-	-	-	-	0.04
Total Assets	2.01	1.99	1.98	2.08	4.15
Accounts Payable	0.35	0.58	0.33	0.71	0.85
Accrued Expenses	0.03	0.03	-	-	0.36
Short-Term Debt	-	-	-	0.05	1.2
Current Portion of Long-Term Debt	0.06	-	-	0.03	1.33
Current Portion of Leases	-	-	-	-	0
Other Current Liabilities	-	-	-	3.62	-
Total Current Liabilities	0.44	0.6	0.33	4.41	3.75
Long-Term Debt	-	0.05	0.04	-	1.25
Total Liabilities	0.44	0.65	0.37	4.41	5.01
Common Stock	18.01	17.68	17.68	18.45	18.38
Retained Earnings	-23.94	-23.83	-23.57	-27.5	-26.08
Comprehensive Income & Other	7.5	7.5	7.5	7.08	7.17
Total Common Equity	1.58	1.34	1.6	-1.98	-0.53
Minority Interest	-	-	-	-0.35	-0.32
Shareholders' Equity	1.58	1.34	1.6	-2.33	-0.85
Total Liabilities & Equity	2.01	1.99	1.98	2.08	4.15
Total Debt	0.06	0.05	0.04	0.08	3.79
Net Cash (Debt)	-0.02	-0.03	-0.04	-0.04	-3.63
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.32
Filing Date Shares Outstanding	20.21	10.44	10.44	12.1	11.85
Total Common Shares Outstanding	20.21	10.44	10.44	12.1	11.85
Working Capital	-0.39	-0.58	-0.32	-4.29	-1.62
Book Value Per Share	0.08	0.13	0.15	-0.16	-0.04
Tangible Book Value	1.58	1.34	1.6	-1.98	-0.53
Tangible Book Value Per Share	0.08	0.13	0.15	-0.16	-0.05
Machinery	-	-	-	-	0.57